- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE introduces mobile PET camera
Riding the wave of increased interest in dedicated PET systems, GE Medical Systems presented a mobile version of its Advance dedicated PET unit at the RSNA show. Mobile PET Advance was featured on panels in GE’s booth, and a unit was displayed in
Riding the wave of increased interest in dedicated PET systems, GE Medical Systems presented a mobile version of its Advance dedicated PET unit at the RSNA show. Mobile PET Advance was featured on panels in GEs booth, and a unit was displayed in the booth of the Waukesha, WI-based firms mobile partner, Calumet Coach. GE plans to certify two other mobile providers in the next few months, and expects to begin shipping the unit in the 0second quarter.
The company has placed more than 100 Advance PET systems worldwide since the units launch. GE is now shipping one Advance per week, and expects sales to double in the coming year, according to Beth Klein, general manager of GEs global nuclear/PET business.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
